Blog
Breakthrough: Blood Test Makes it Possible to Track Alzheimer’s Advancement
A connection between Neurofilament light (NfL) levels present in the blood and Alzheimer’s disease was recently made in a study released by the JAMA Network.
New Study Might Diagnose CTE in Brains of the Living
A recent study published in the New England Journal of medicine revealed that brain scans of more than two dozen former NFL players found that the men had abnormal levels of the protein linked to chronic traumatic encephalopathy (C.T.E.), the degenerative brain disease we have discussed here that’s associated with repeated hits to the head.
JUST PUT DOWN THE SUPPLEMENTS
There have long been debates among established medical authorities and supplement manufacturers, especially when it comes to treating cognitive decline. Are the myriad of supplements currently on the market a genie in a bottle? Or is it better to focus on leading a healthy, balanced lifestyle?
BREAKING NEWS: Promising Alzheimer’s Drug Fails in Late-Stage Human Trials
Another big blow came to the Alzheimer’s research community late last month when pharmaceutical company Biogen and Eisai Co. announced on March 22 that they would terminate two late-stage studies of the experimental drug aducanumab. They have ceased trials after they determined it would likely fail to help patients. This announcement is the latest in a long line of failed Alzheimer’s drugs...
Could a Noninvasive Eye Exam Preemptively Diagnose Alzheimer’s Disease?
That’s what a recent study conducted at the Duke Eye Center suggests. The study of more than 200 people, published on March 11 in the journal Ophthalmology Retina, proposes that a quick, noninvasive eye exam might one day allow eye doctors to check up on both your vision prescription and your brain health. Healthy vs. Alzheimer’s-Affected Brains The study looked at the eyes of individuals...
Tom Seaver Diagnosis Reignites Lyme Disease & Dementia Debate
AN ARTICLE IN The New York Times recently revealed that Tom Seaver, legendary pitcher and the most prominent player in New York Mets history, is stepping back from public life because of advancing dementia. It was recently discovered that Seaver, 74, has dementia. However, for many years he suffered from the effects of Lyme disease, which can cause cognitive problems similar to dementia.